Related Experiment Video
Updated: May 22, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
P2X7 Receptor Activation Triggers a Neuroinflammatory Cascade Driving Migraine Pathophysiology: Implications for
Yihan Hu1, Yine Song1, Shaoru Zhao1
1Department of Acupuncture and Moxibustion, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Key Laboratory of Acupuncture Neuromodulation, Beijing, China.
Abstract:
Migraine, a disabling neurological disorder, is increasingly recognized as being driven by neuroinflammatory processes. Purinergic receptor P2X ligand-gated ion channel 7 (P2X7R), an ATP-gated ion channel highly expressed in microglia, astrocytes, and neurons, has emerged as a pivotal regulator of these neuroimmune responses. This narrative review synthesizes the literature on P2X7R-mediated neuroinflammation and glial modulation in migraine. Evidence indicates that P2X7R activation triggers a cascade of pro-inflammatory events, including Pannexin-1 (PANX1) channel opening, NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome assembly, and the release of cytokines such as Interleukin-1β (IL-1β) and Tumor necrosis factor-α (TNF-α). Concurrently, it activates p38 MAPK and Nuclear factor kappa B (NF-κB) signaling pathways, thereby amplifying glial pro-inflammatory phenotypes and facilitating key migraine phenomena like cortical spreading depression (CSD) and trigeminovascular activation. Consistently, pharmacological or genetic inhibition of P2X7R has been shown to attenuate CSD, pain behaviors, and associated cognitive deficits in animal models of migraine. The receptor's involvement is further underscored by its link to autophagy dysfunction and central sensitization, highlighting its broad role in migraine chronification. Although these findings position P2X7R as a master regulator of neuroinflammation in migraine by integrating glial activation, cytokine release, and neuronal sensitization, most supporting evidence currently derives from animal models, a crucial point to note. This limitation, alongside heterogeneity in experimental designs, underscores the need for more translational research in humans. Nonetheless, given its central role, P2X7R inhibition emerges as a promising disease-modifying therapeutic strategy, potentially by counteracting core pathophysiological drivers of migraine.
Insights
Purinergic receptor P2X7R drives neuroinflammation in migraine by activating glial cells and releasing inflammatory cytokines. Inhibiting P2X7R shows promise for treating migraine by targeting core disease mechanisms.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Migraine is a neurological disorder linked to neuroinflammation.
- Purinergic receptor P2X7R (P2X7R) is a key regulator of neuroimmune responses, expressed in brain cells like microglia and astrocytes.
Purpose of the Study:
- To review the literature on P2X7R-mediated neuroinflammation and glial cell modulation in migraine pathophysiology.
- To explore P2X7R as a potential therapeutic target for migraine.
Main Methods:
- Narrative literature review synthesizing studies on P2X7R in migraine.
- Analysis of P2X7R's role in glial activation, cytokine release, and neuronal sensitization.
Main Results:
- P2X7R activation triggers neuroinflammation via Pannexin-1 (PANX1) and NLRP3 inflammasome, releasing IL-1β and TNF-α.
- P2X7R signaling pathways (p38 MAPK, NF-κB) amplify glial responses, contributing to cortical spreading depression (CSD) and trigeminovascular activation.
- Inhibition of P2X7R in animal models reduced CSD, pain, and cognitive deficits, suggesting a role in migraine chronification.
Conclusions:
- P2X7R is a central regulator of neuroinflammation in migraine, linking glial activation, cytokine release, and neuronal sensitization.
- While promising, current evidence is largely from animal models, necessitating further human translational research.
- P2X7R inhibition represents a potential disease-modifying therapeutic strategy for migraine.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Acute Inflammation III: Local and Systemic Effects
Analgesia and Pain Management
Encephalitis ll: Pathophysiology
Nociception
